Promising compound kills range of hard-to-treat cancers by targeting a previously undiscovered vulnerability

June 2, 2022

ERX-41, developed by UT Health San Antonio scientists, exploits a previously unrecognized weakness in breast cancer and other solid tumors. Media contact: Will Sansom, 210-567-2579, Sansom@uthscsa.edu SAN ANTONIO (June 2, 2022) – A compound, developed by a team including scientists from The University of Texas Health Science Center at San Antonio, kills a range of hard-to-treat cancer […]

Erase Cancer



The massive need for equitable Latino representation in clinical trials

May 24, 2022

Media contact: Will Sansom, 210-567-2579, sansom@uthscsa.edu Contributed and written by Cliff Despres, Institute for Health Promotion Research SAN ANTONIO (May 24, 2022) — Latinos represent less than 10% of volunteers in cancer clinical trials. The lack of Latinos in clinical trials makes it harder for researchers to find treatments tailored for this group — which […]

Photo of Hispanic family


Noted cancer researcher receives UT System Faculty STARs award

April 1, 2022

Daohong Zhou, MD, a professor with tenure in the Department of Biochemistry and Structural Biology in the Joe R. and Teresa Lozano Long School of Medicine at UT Health San Antonio, has received a UT System Faculty STARs award in the amount of $1,487,563 to support his drug discovery research.

Star trophy with blue background.


Oral Cancer Awareness month: What you need to know

March 31, 2022

The UT Health San Antonio School of Dentistry has partnered with The Oral Cancer Foundation to host The San Antonio Oral Cancer Walk on Saturday, April 23, in observance of the 22nd Annual Oral Cancer Awareness Month.




Black patients with cancer fare worse with COVID-19, study shows

March 28, 2022

Structural racism, rather than disease, leads to inequities, authors write Contacts: Will Sansom, (210) 567-2579, sansom@uthscsa.edu Steven Lee, (210) 450-3823, lees22@uthscsa.edu SAN ANTONIO (March 28, 2022) — Black patients with cancer experienced significantly worse outcomes after COVID-19 diagnosis than non-Hispanic white cancer patients in a study published March 28 in JAMA Network Open. Investigators of […]